INTERNATIONAL PATENT: THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES FILES APPLICATION FOR "2,4-DIPHENYL-3,4-DIHYDROQUINAZOLINE DERIVATIVES AND RELATED COMPOUNDS AS D2 DOPAMINE RECEPTOR-SELECTIVE ANTAGONISTS"

GENEVA, Jan. 13 -- THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (National Institutes of HealthOffice of Technology Transfer6701 Rockledge Drive, Suite 700, MSC 7788Bethesda, MD 20892-7788) filed a patent application (PCT/US2025/035353) for "2,4-DIPHENYL-3,4-DIHYDROQUINAZOLINE DERIVATIVES AND RELATED COMPOUNDS AS D2 DOPAMINE RECEPTOR-SELECTIVE ANTAGONISTS" on Jun 26, 2025. With publication no. WO/2026/010789, the details related to the patent application was published on Jan 08, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SIBLEY, David,...